CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on creating a novel vaccine technology using biocompatible hydrogels and polymersomes to provide a controlled and sustained immune response against SARS-CoV-2. It aims to enhance vaccine efficacy through improved antigen presentation and immune stimulation, addressing the challenges of vaccine dist…
In light of current events, developing new technologies for the fight against severe infectious diseases, such as the COVID-19 pandemic caused by the SARS-CoV-2 virus, is a global health emergency.
Despite the tremendous improvement of vaccine technologies, the design of potent, durable and safe vaccines displaying an ease of distribution and a reduced cost, remains a major technological challenge.
This research project proposes to develop a novel biocompatible, injectable and scalable vaccine t…
UNIVERSITE DE BORDEAUX
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
United States, Stanford
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
